Suppression of ERα activity by COUP-TFII is essential for successful implantation and decidualization

Dong Kee Lee, Isao Kurihara, Jae Wook Jeong, John P. Lydon, Francesco J. DeMayo, Ming Jer Tsai, Sophia Y. Tsai

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Synchrony between embryo competency and uterine receptivity is essential for successful implantation. Mice with ablation of chicken ovalbumin upstream promoter-transcription factor II (COUPTFII) in the uterus (PR Cre/+;COUP-TFIIflox/flox) exhibit implantation defects and increased estrogen receptor (ER)α activity in the luminal epithelium, suggesting high ERα activity may disrupt the window of uterine receptivity. To determine whether increased ERα activity in the PR Cre/+;COUPTFIIflox/flox uterus is the cause of defective implantation, we assessed whether inhibition of ERα activity could rescue the PRCre/+;COUP-TFIIflox/flox uterine implantation defect. ICI 182,780 (ICI), a pure ERα antagonist, was administered to PRCre/+;COUP-TFIIflox/flox mutant and COUP-TFII flox/flox control mice during the receptive period, and the number of implantation sites was examined. COUP-TFIIflox/flox control mice treated with oil or ICI showed the normal number of implantation sites. As expected, no implantation sites were observed in PRCre/+;COUP- TFIIflox/flox mutant mice treated with oil, consistent with previous observations. In contrast, implantation sites were greatly increased in ICI-treated PRCre/+;COUP-TFIIflox/flox mutant mice, albeit at a reduced number in comparison with the control mice. ICI treatment was also able to restore the expression of Wnt4 and bone morphogenetic protein 2, important for endometrial decidualization in the PRCre/+; COUP-TFIIflox/flox mutant mice. To confirm that the rescue of embryo attachment and decidualization is a consequence of a reduced ERα activity upon ICI treatment, we showed a reduction of the expression of ERα target genes in PRCre/+;COUP-TFIIflox/flox mutant mice. Because COUP-TFII was also shown in our laboratory to be important for placentation during pregnancy, we asked whether ICI treatment could also rescue the placentation defect to allow full-term pregnancy in these mice. We found that whereas mice were born in COUP-TFIIflox/flox control mice given ICI, no pups were born in the PRCre/+;COUP-TFIIflox/flox mutant mice, suggesting that the increased ERα activity is not the reason for placentation defects. These results demonstrate that during the periimplantation period, COUP-TFII regulates embryo attachment and decidualization through controlling ERα activity. However, COUP-TFII expression is still required in the postimplantation period to facilitate placentation.

Original languageEnglish
Pages (from-to)930-940
Number of pages11
JournalMolecular Endocrinology
Volume24
Issue number5
DOIs
Publication statusPublished - 2010 May

Fingerprint

Estrogen Receptors
Placentation
Embryonic Structures
COUP Transcription Factor II
Uterus
Oils
Bone Morphogenetic Protein 2
Pregnancy
Epithelium

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology
  • Medicine(all)

Cite this

Suppression of ERα activity by COUP-TFII is essential for successful implantation and decidualization. / Lee, Dong Kee; Kurihara, Isao; Jeong, Jae Wook; Lydon, John P.; DeMayo, Francesco J.; Tsai, Ming Jer; Tsai, Sophia Y.

In: Molecular Endocrinology, Vol. 24, No. 5, 05.2010, p. 930-940.

Research output: Contribution to journalArticle

Lee, Dong Kee ; Kurihara, Isao ; Jeong, Jae Wook ; Lydon, John P. ; DeMayo, Francesco J. ; Tsai, Ming Jer ; Tsai, Sophia Y. / Suppression of ERα activity by COUP-TFII is essential for successful implantation and decidualization. In: Molecular Endocrinology. 2010 ; Vol. 24, No. 5. pp. 930-940.
@article{d095d18edf81445dadf34896f6c871bc,
title = "Suppression of ERα activity by COUP-TFII is essential for successful implantation and decidualization",
abstract = "Synchrony between embryo competency and uterine receptivity is essential for successful implantation. Mice with ablation of chicken ovalbumin upstream promoter-transcription factor II (COUPTFII) in the uterus (PR Cre/+;COUP-TFIIflox/flox) exhibit implantation defects and increased estrogen receptor (ER)α activity in the luminal epithelium, suggesting high ERα activity may disrupt the window of uterine receptivity. To determine whether increased ERα activity in the PR Cre/+;COUPTFIIflox/flox uterus is the cause of defective implantation, we assessed whether inhibition of ERα activity could rescue the PRCre/+;COUP-TFIIflox/flox uterine implantation defect. ICI 182,780 (ICI), a pure ERα antagonist, was administered to PRCre/+;COUP-TFIIflox/flox mutant and COUP-TFII flox/flox control mice during the receptive period, and the number of implantation sites was examined. COUP-TFIIflox/flox control mice treated with oil or ICI showed the normal number of implantation sites. As expected, no implantation sites were observed in PRCre/+;COUP- TFIIflox/flox mutant mice treated with oil, consistent with previous observations. In contrast, implantation sites were greatly increased in ICI-treated PRCre/+;COUP-TFIIflox/flox mutant mice, albeit at a reduced number in comparison with the control mice. ICI treatment was also able to restore the expression of Wnt4 and bone morphogenetic protein 2, important for endometrial decidualization in the PRCre/+; COUP-TFIIflox/flox mutant mice. To confirm that the rescue of embryo attachment and decidualization is a consequence of a reduced ERα activity upon ICI treatment, we showed a reduction of the expression of ERα target genes in PRCre/+;COUP-TFIIflox/flox mutant mice. Because COUP-TFII was also shown in our laboratory to be important for placentation during pregnancy, we asked whether ICI treatment could also rescue the placentation defect to allow full-term pregnancy in these mice. We found that whereas mice were born in COUP-TFIIflox/flox control mice given ICI, no pups were born in the PRCre/+;COUP-TFIIflox/flox mutant mice, suggesting that the increased ERα activity is not the reason for placentation defects. These results demonstrate that during the periimplantation period, COUP-TFII regulates embryo attachment and decidualization through controlling ERα activity. However, COUP-TFII expression is still required in the postimplantation period to facilitate placentation.",
author = "Lee, {Dong Kee} and Isao Kurihara and Jeong, {Jae Wook} and Lydon, {John P.} and DeMayo, {Francesco J.} and Tsai, {Ming Jer} and Tsai, {Sophia Y.}",
year = "2010",
month = "5",
doi = "10.1210/me.2009-0531",
language = "English",
volume = "24",
pages = "930--940",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Suppression of ERα activity by COUP-TFII is essential for successful implantation and decidualization

AU - Lee, Dong Kee

AU - Kurihara, Isao

AU - Jeong, Jae Wook

AU - Lydon, John P.

AU - DeMayo, Francesco J.

AU - Tsai, Ming Jer

AU - Tsai, Sophia Y.

PY - 2010/5

Y1 - 2010/5

N2 - Synchrony between embryo competency and uterine receptivity is essential for successful implantation. Mice with ablation of chicken ovalbumin upstream promoter-transcription factor II (COUPTFII) in the uterus (PR Cre/+;COUP-TFIIflox/flox) exhibit implantation defects and increased estrogen receptor (ER)α activity in the luminal epithelium, suggesting high ERα activity may disrupt the window of uterine receptivity. To determine whether increased ERα activity in the PR Cre/+;COUPTFIIflox/flox uterus is the cause of defective implantation, we assessed whether inhibition of ERα activity could rescue the PRCre/+;COUP-TFIIflox/flox uterine implantation defect. ICI 182,780 (ICI), a pure ERα antagonist, was administered to PRCre/+;COUP-TFIIflox/flox mutant and COUP-TFII flox/flox control mice during the receptive period, and the number of implantation sites was examined. COUP-TFIIflox/flox control mice treated with oil or ICI showed the normal number of implantation sites. As expected, no implantation sites were observed in PRCre/+;COUP- TFIIflox/flox mutant mice treated with oil, consistent with previous observations. In contrast, implantation sites were greatly increased in ICI-treated PRCre/+;COUP-TFIIflox/flox mutant mice, albeit at a reduced number in comparison with the control mice. ICI treatment was also able to restore the expression of Wnt4 and bone morphogenetic protein 2, important for endometrial decidualization in the PRCre/+; COUP-TFIIflox/flox mutant mice. To confirm that the rescue of embryo attachment and decidualization is a consequence of a reduced ERα activity upon ICI treatment, we showed a reduction of the expression of ERα target genes in PRCre/+;COUP-TFIIflox/flox mutant mice. Because COUP-TFII was also shown in our laboratory to be important for placentation during pregnancy, we asked whether ICI treatment could also rescue the placentation defect to allow full-term pregnancy in these mice. We found that whereas mice were born in COUP-TFIIflox/flox control mice given ICI, no pups were born in the PRCre/+;COUP-TFIIflox/flox mutant mice, suggesting that the increased ERα activity is not the reason for placentation defects. These results demonstrate that during the periimplantation period, COUP-TFII regulates embryo attachment and decidualization through controlling ERα activity. However, COUP-TFII expression is still required in the postimplantation period to facilitate placentation.

AB - Synchrony between embryo competency and uterine receptivity is essential for successful implantation. Mice with ablation of chicken ovalbumin upstream promoter-transcription factor II (COUPTFII) in the uterus (PR Cre/+;COUP-TFIIflox/flox) exhibit implantation defects and increased estrogen receptor (ER)α activity in the luminal epithelium, suggesting high ERα activity may disrupt the window of uterine receptivity. To determine whether increased ERα activity in the PR Cre/+;COUPTFIIflox/flox uterus is the cause of defective implantation, we assessed whether inhibition of ERα activity could rescue the PRCre/+;COUP-TFIIflox/flox uterine implantation defect. ICI 182,780 (ICI), a pure ERα antagonist, was administered to PRCre/+;COUP-TFIIflox/flox mutant and COUP-TFII flox/flox control mice during the receptive period, and the number of implantation sites was examined. COUP-TFIIflox/flox control mice treated with oil or ICI showed the normal number of implantation sites. As expected, no implantation sites were observed in PRCre/+;COUP- TFIIflox/flox mutant mice treated with oil, consistent with previous observations. In contrast, implantation sites were greatly increased in ICI-treated PRCre/+;COUP-TFIIflox/flox mutant mice, albeit at a reduced number in comparison with the control mice. ICI treatment was also able to restore the expression of Wnt4 and bone morphogenetic protein 2, important for endometrial decidualization in the PRCre/+; COUP-TFIIflox/flox mutant mice. To confirm that the rescue of embryo attachment and decidualization is a consequence of a reduced ERα activity upon ICI treatment, we showed a reduction of the expression of ERα target genes in PRCre/+;COUP-TFIIflox/flox mutant mice. Because COUP-TFII was also shown in our laboratory to be important for placentation during pregnancy, we asked whether ICI treatment could also rescue the placentation defect to allow full-term pregnancy in these mice. We found that whereas mice were born in COUP-TFIIflox/flox control mice given ICI, no pups were born in the PRCre/+;COUP-TFIIflox/flox mutant mice, suggesting that the increased ERα activity is not the reason for placentation defects. These results demonstrate that during the periimplantation period, COUP-TFII regulates embryo attachment and decidualization through controlling ERα activity. However, COUP-TFII expression is still required in the postimplantation period to facilitate placentation.

UR - http://www.scopus.com/inward/record.url?scp=77954838585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954838585&partnerID=8YFLogxK

U2 - 10.1210/me.2009-0531

DO - 10.1210/me.2009-0531

M3 - Article

C2 - 20219888

AN - SCOPUS:77954838585

VL - 24

SP - 930

EP - 940

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 5

ER -